Reclassification Problem

The reclassification problem refers to how mesothelioma cases that were once labeled as something else (such as lung cancer, ovarian cancer, or unspecified abdominal tumors) are now being correctly identified as mesothelioma thanks to better pathology and immunohistochemistry. This shift means that historical disease counts likely undercounted asbestos-related cancers, and some cancers historically attributed to other causes were in fact caused by asbestos exposure. In epidemiology and litigation, the problem is that older studies and death certificates may not reliably reflect the true burden of asbestos disease.

Origin

The concept emerged as diagnostic pathology advanced from the 1970s through the 1990s, when immunohistochemical stains (calretinin, WT-1, cytokeratin 5/6, and others) made it possible to distinguish mesothelioma from adenocarcinoma and other tumors with high reliability. Epidemiologists studying asbestos cohorts noted that earlier death certificate data systematically misclassified mesotheliomas, leading to formal discussion of the "reclassification problem" in occupational disease literature.

Significance in Asbestos Context

For patients and families, this concept matters in two practical ways. First, if a loved one died years ago with a diagnosis like "lung cancer," "peritoneal carcinomatosis," or "ovarian cancer," preserved tissue blocks can sometimes be re-examined today and the true diagnosis confirmed as mesothelioma, which can open the door to a claim. Second, defendants in asbestos cases sometimes argue that older epidemiology overstates asbestos risk because of reclassification; plaintiff experts respond that the historical record more often undercounted asbestos disease, not the reverse. Your legal and medical team may pursue archived pathology slides from hospitals or pathology labs to confirm or reclassify a prior diagnosis.

Example Sentence

After her mother's death from what was called "ovarian cancer" in 1995, the family had the original tissue blocks re-tested and the reclassification confirmed peritoneal mesothelioma, allowing them to file a claim tied to her husband's shipyard work.

Related Terms

Immunohistochemistry, Peritoneal Mesothelioma, Death Certificate Studies, Misdiagnosis, Pathology Review, Latency

Notes

• If a family member died of an abdominal, lung, or pleural cancer years ago and had any asbestos exposure history, ask the hospital pathology department whether the paraffin tissue blocks are still archived. Most labs retain them for 10–20 years or longer.
• Request a second pathology review by a mesothelioma-experienced pathologist using modern immunohistochemical stains; this can change a diagnosis and the legal options available.
• Preserve all original pathology reports, slides, and death certificates; these documents are essential both to reclassification efforts and to any resulting claim.
• Be aware that defense experts may cite the reclassification problem to challenge older epidemiology; your attorney's experts should be prepared to address it directly.